B. Schmied

发表

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

HIV–HCV co‐infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

A. Rieger, A. Gangl, T. Reiberger, 2009, Journal of viral hepatitis.

A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin

A. Rieger, M. Trauner, T. Reiberger, 2012, Antiviral therapy.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

A. Mocroft, O. Kirk, J. Lundgren, 2018, AIDS.

German-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008

B. Buchholz, A. Gingelmaier, U. Marcus, 2009, European journal of medical research.

Observational cohort study of rilpivirine (RPV) utilization in Europe

C. Leen, A. Mocroft, R. Paredes, 2022, AIDS Research and Therapy.

A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study

Z. El-Khatib, B. Ledergerber, A. Rieger, 2021, International journal of environmental research and public health.

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

A. Mocroft, O. Kirk, D. Raben, 2021, HIV research & clinical practice.

Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV

A. Mocroft, P. Reiss, J. Reekie, 2022, AIDS.

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial.

M. Das, J. Lelièvre, J. Slim, 2019, The lancet. HIV.

Quality of life of HIV-infected patients: Psychometric properties and validation of the German version of the MQOL-HIV

H. Hinterhuber, G. Kemmler, G. Schüssler, 2003, Quality of Life Research.

Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV‐1 drug resistance

C. Mandl, F. Heinz, E. Puchhammer-Stöckl, 1999, Journal of medical virology.

Cytomegalovirus genotypes present in cerebrospinal fluid of HIV-infected patients

E. Puchhammer-Stöckl, C. Steininger, M. Geit, 2005, AIDS.

Comparison of Sequence Analysis and the INNO-LiPA HBV DR Line Probe Assay for Detection of Lamivudine-Resistant Hepatitis B Virus Strains in Patients under Various Clinical Conditions

E. Puchhammer-Stöckl, N. Vetter, B. Watschinger, 2001, Journal of Clinical Microbiology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Low Proportion of Recent Human Immunodeficiency Virus (HIV) Infections among Newly Diagnosed Cases of HIV Infection as Shown by the Presence of HIV-Specific Antibodies of Low Avidity

A. Rieger, E. Puchhammer-Stöckl, M. Geit, 2005, Journal of Clinical Microbiology.

HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection

A. Rieger, E. Puchhammer-Stöckl, K. Grabmeier-Pfistershammer, 2010, AIDS.

Diagnostics and treatment of HIV-affected couples who wish to have children.

P. Vernazza, K. Friese, M. Kupka, 2008, European journal of medical research.

DIAGNOSTICSANDTREATMENTOFHIV-AFFECTEDCOUPLES WHOWISHTOHAVECHILDREN

K. Friese, M. Kupka, N. Brockmeyer, 2008 .

German-Austrian recommendations for HIV-therapy in pregnancy and in HIV-exposed newborn - update 2005.

B. Buchholz, N. Brockmeyer, A. Gingelmaier, 2006, European journal of medical research.